For decades, Africa’s public health systems have depended heavily on imported diagnostics to support disease detection, surveillance, and treatment programmes. While these products often meet global quality standards, the model has left countries exposed to supply disruptions, long lead times, and
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
